These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1005 related articles for article (PubMed ID: 17522512)
1. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
2. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370 [TBL] [Abstract][Full Text] [Related]
3. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
4. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427 [TBL] [Abstract][Full Text] [Related]
5. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer]. de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213 [TBL] [Abstract][Full Text] [Related]
10. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cisco RM; Ford JM; Norton JA Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546 [TBL] [Abstract][Full Text] [Related]
11. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394 [TBL] [Abstract][Full Text] [Related]
14. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432 [TBL] [Abstract][Full Text] [Related]
15. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers. Lee AF; Rees H; Owen DA; Huntsman DG Am J Surg Pathol; 2010 Jul; 34(7):1007-13. PubMed ID: 20534996 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic total gastrectomy for familial gastric cancer. Lewis FR; Mellinger JD; Hayashi A; Lorelli D; Monaghan KG; Carneiro F; Huntsman DG; Jackson CE; Caldas C Surgery; 2001 Oct; 130(4):612-7; discussion 617-9. PubMed ID: 11602891 [TBL] [Abstract][Full Text] [Related]
17. CDH1 associated gastric cancer: a report of a family and review of the literature. Moran CJ; Joyce M; McAnena OJ Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560 [TBL] [Abstract][Full Text] [Related]
18. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763 [TBL] [Abstract][Full Text] [Related]
19. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome. Newman EA; Mulholland MW J Am Coll Surg; 2006 Apr; 202(4):612-7. PubMed ID: 16571431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]